2009
DOI: 10.1039/b909646a
|View full text |Cite
|
Sign up to set email alerts
|

Syntheses of naturally occurring cytotoxic [7.7]paracyclophanes, (−)-cylindrocyclophane A and its enantiomer, and implications for biological activity

Abstract: The total syntheses of (-)-cylindrocyclophane A (1), a naturally occurring, cytotoxic [7.7]paracyclophane, and its enantiomer have been achieved in an enantiodivergent manner starting from a chiral propargyl alcohol building block using Smith's cross metathesis/ring-closing metathesis protocol as the key step. The biological evaluation of both enantiomers of cylindrocyclophane A (1 and ent-1) and its analogues indicated that the chirality of 1 is irrelevant to its cytotoxicity, which is attributed to the resor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 39 publications
(11 reference statements)
1
23
0
Order By: Relevance
“…Merocyclophanes A and B ( 1 and 2 ) possessed similar levels of antiproliferative activity as those reported for cylindrocyclophanes A–F against various cell lines (0.5 – 5 µg/mL). A SAR study on cyclindrocyclophane A suggested that the 2,5-dialkylresorcinol moiety was the pharmacophore needed for the antiproliferative activity of cylindrocyclophanes, and that the activity was significantly enhanced by the presence of [7.7]paracyclophane core structure (Yamakoshi et al, 2009). The structure of merocyclophane A ( 1 ) differs from that of cyclindrocyclophane A by the position of methyl groups and the lack of alkyl hydroxy groups; however, both compounds showed a similar level of activity.…”
Section: Resultsmentioning
confidence: 99%
“…Merocyclophanes A and B ( 1 and 2 ) possessed similar levels of antiproliferative activity as those reported for cylindrocyclophanes A–F against various cell lines (0.5 – 5 µg/mL). A SAR study on cyclindrocyclophane A suggested that the 2,5-dialkylresorcinol moiety was the pharmacophore needed for the antiproliferative activity of cylindrocyclophanes, and that the activity was significantly enhanced by the presence of [7.7]paracyclophane core structure (Yamakoshi et al, 2009). The structure of merocyclophane A ( 1 ) differs from that of cyclindrocyclophane A by the position of methyl groups and the lack of alkyl hydroxy groups; however, both compounds showed a similar level of activity.…”
Section: Resultsmentioning
confidence: 99%
“…It was speculated that this highly gratifying result was a consequence of the reversible nature of the RCM reaction and the low‐energy nature of 258 a – b . Indeed, it was subsequently shown that trienes ( E )‐ 259 and ( Z )‐ 259 (precursors to head‐to‐head [8.6]cyclophanes) also afforded cylindrocyclophane F ( 27 b ) in 75–81 % yield!148 The cross‐metathesis/RCM reaction was recently repeated by other researchers in a synthesis of cylindrocyclophane F and its enantiomer 149…”
Section: Ring‐closing Metathesismentioning
confidence: 99%
“…The anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate derivatives (Mehellou et al, 2009) Potential anti-cancer compounds have been reported including a poly-THF spiroketalcontaining compound which is active against both breast and ovarian cancer cell lines (Piccialli et al, 2009). Both enantiomers of (-)-cylindrocyclophane were synthesised and found to have very similar activities against the human colon cancer HCT-116 cells (Yamakoshi et al, 2009). Iron(III)-salen complexes were used to demonstrate that, somewhat surprisingly, the less DNA cleavage activity these compounds showed in vitro, the more efficient they were at inducing apoptosis in MCF7 cells (Ansari et al, 2009).…”
Section: Bioactivesmentioning
confidence: 99%